Two Sigma Investments’s NervGen Pharma NGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding NGEN
Two Sigma Investments's NGEN Position: Q3 2026 in Review
Two Sigma Investments opened a new position in NervGen Pharma (NGEN) in Q3 2026: 463,494 shares worth $885K. The stake represents ﹤0.01% of the portfolio and ranks #3678 among its holdings.
68 funds tracked by Wall St. Rank hold NGEN as of Q3 2026.
- Two Sigma Investments held 463,494 shares of NervGen Pharma worth $885K as of Q3 2026.
- NervGen Pharma was a new Two Sigma Investments position in Q3 2026.
- NervGen Pharma made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #3678 holding.
- 68 funds tracked by Wall St. Rank held NervGen Pharma as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.